Healthcare Administrative Automation
Q

Quench

Quench reviews medical records for the medicolegal market, not for clinical care, so it is filed under administrative automation alongside the other insurance and legal record review products rather than under clinical summarisation.

Quench SmartChart takes the thousands of page PDFs that arrive in a medicolegal matter, organises them, identifies records that appear to be missing, and produces a chronology of the case. A natural language interface called AskQuench lets a reviewer interrogate the file and returns documented answers, and findings can be saved as the reviewer works and referenced later in a report. Records are reviewed inside the platform rather than in a separate viewer.

The founder and chief executive is Michael D. Lesh, a cardiologist and adjunct professor of medicine at the University of California San Francisco who left practice to become a medical device entrepreneur, and the company describes its platform as physician engineered. Two clinical advisers appear on the record with verifiable positions: an associate medical director in enterprise occupational health at the Cleveland Clinic, and the chief of occupational health at a Department of Veterans Affairs healthcare system.

Users are physicians and nurses acting as expert witnesses, independent and qualified medical evaluators, law firms and insurance companies, working on workers compensation claims, standard of care questions, defective product injury, litigation, claims disputes and underwriting.

The reason this record is worth reading alongside the other medicolegal products is a line the company publishes about what it will not do. Asked whether the AI performs legal tasks, Quench answers plainly that it does not cite cases or draw conclusions, and that the system exists to organise documents, provide a chronology and help a reviewer find relevant information. In a market where a direct competitor markets inference as its differentiator, that is a deliberate scope limitation and it is discussed on the autonomy and governance axes.

AI Health Index verifiedJuly 24, 2026
Compare Quench with other vendors
Founded
Headquarters
Categories
healthcare-admin-automation
Assessment

Capability Axes

An AI Health Index grade measures what a buyer can verify from public sources on the date shown. It is not a rating of how good the product is. A vendor can build an excellent system and grade low on an axis because it publishes nothing an outsider can check. How grades read

AI Capability
AA on AI CentralityThe artificial intelligence is the product. Remove the model and there is nothing left to sell.
Vendor Published

Extraction, summarisation, chronology construction and natural language interrogation of the record are the product, with no services organisation or prior software underneath. The founder states the company built its own engineering rather than wrapping a general purpose model, framing the work as proprietary and grounded in the team's clinical and data science background. That assertion could not be independently verified and is recorded rather than credited, but the product itself is unambiguously model driven.

BB on Autonomy and Oversight ModelThe oversight structure is described and one part is missing, commonly the threshold at which the system stops or what happens after it is wrong.
Vendor Published

Oversight here is achieved by scope limitation rather than by adding a check, which for this use case is the stronger approach because it removes the inference surface instead of monitoring it. Quench states publicly that its AI does not perform legal tasks such as citing cases or drawing conclusions, and that the system exists to organise documents, provide a chronology and help a reviewer find relevant information. Evaluation, findings and conclusions remain with the professional.

Supporting that, the interface returns documented answers, findings are saved as the reviewer works rather than generated wholesale at the end, and the chronologies are framed as defensible.

Held at B because nothing is quantified: no accuracy rate for the chronology or the missing record detection, no confidence signal, no abstention behaviour, and no specification of what documented means at the level of an individual answer. Ask what a documented answer cites, and at what granularity.

CC on Model and Technology TransparencyThe architecture is described in general terms with nothing identified. Proprietary is asserted rather than explained.
Vendor Published

An unusual inversion of the normal gap. Most vendors in this index say nothing about what they run on. This one says what it is NOT, with the founder stating it is not ChatGPT and not just a wrapper and describing sophisticated proprietary engineering, without saying what the stack actually is. A negative claim is not a disclosure.

No model or model family is named, no accuracy figure exists for extraction, chronology construction or the question answering interface, and no evaluation methodology was located. AskQuench is described as returning documented answers, which suggests citation to source, but the granularity is unspecified.

CC on Model Supply Chain DisclosureThe architecture is described and no provider is named.
Vendor Published

More operational detail than most of this group, and the same lifecycle gaps. The company describes encrypted transmission and storage, access controls restricting patient information to authorised personnel, background checks on all employees before employment, security training at onboarding and annually, a named privacy officer directing security, and a named cloud host.

Several of those are rarely stated at all, and the personnel controls are the ones worth crediting specifically: pre employment screening and recurring training address the insider path, which is where a document review business is most exposed and which almost every vendor in this index leaves unmentioned while describing encryption at length. Naming the privacy officer gives an outside party someone to write to. What is absent is the lifecycle.

No retention period, no statement on whether uploaded records are used to train or improve models, no de identification posture, and no sub processor list. The data subject position matches the rest of this group and bears on how much the vendor should publish: the person whose records are reviewed is an examinee, a claimant or an opposing party who has no relationship with the vendor, did not choose it, and has no route to ask what was held or for how long. Ask for retention once a matter closes, the training position in contract language, and what a data subject can obtain about a review of their own file.

CC on Clinical and Operational EvidenceNamed customers, or vendor reported percentages with no method, denominator or reference standard. Scale of use is recorded here and is not treated as evidence of benefit.
Vendor Published

Credentialed voices, no independent evidence. Two named clinical advisers hold verifiable senior positions in occupational health at the Cleveland Clinic and at a Department of Veterans Affairs healthcare system, which is meaningful domain credibility for a medicolegal product.

One caution that applies generally and applies here: the testimonials carried on the site are attributed to those same clinical advisers, so they are endorsements from people affiliated with the company rather than independent customer references, and should not be read as the latter. No customer organisation is named, no funding is disclosed, no accuracy or time saving figure is published, and no independent evaluation was located.

CC on AI Safety and PHI StewardshipGeneral assurances of privacy and security that do not answer the questions artificial intelligence raises: what is retained, what reaches a model, and what happens to it there.
Vendor Published

More operational detail than most of this group and the same gaps. The company describes encrypted transmission and storage, access controls restricting PHI to authorised personnel, background checks on all employees before employment, security training at onboarding and annually, a named Privacy Officer directing security, and Amazon Web Services hosting. Those are real controls and several of them, particularly the background checks and the annual training, are rarely stated at all.

What is absent is the lifecycle: no retention period, no statement on whether uploaded records are used to train or improve models, and no de identification posture. The data subject position also matches the rest of this group, since the person whose records are reviewed is an examinee, a claimant or an opposing party who has no relationship with the vendor and did not choose it.

Regulatory and Compliance
BB on HIPAA and BAA PostureBusiness associate status is stated and supported by a substantive privacy document, with the agreement or its scope not fully published. For a vendor outside the United States, an equivalent regime documented to this depth grades here.
Vendor Published

HIPAA compliance is claimed with more supporting specificity than the norm, covering encryption, access control and a named Privacy Officer, though no business associate agreement terms are published. The market nuance recorded across this group applies with force: independent medical examination, qualified medical evaluation, workers compensation and litigation work frequently sit outside the HIPAA covered entity framework, and records typically arrive under authorisation, subpoena or discovery rather than under treatment provisions. Claiming HIPAA compliance in that context is a credit rather than a requirement. Establish which regime governs the records in your own matters.

CC on Security Certifications and Trust CenterControls are described with an outside check behind them, such as independent penetration testing on a stated cadence, but no attestation against a recognised framework.
Vendor Published

No third party attestation of any kind was located: no SOC 2, no ISO 27001, no HITRUST, and no trust centre. That is what holds this at C.

Against it sits something this index rarely finds and which deserves crediting: a published vulnerability disclosure process, with a named contact address, stated expectations for what a report should contain, a commitment to verify rapidly and to send periodic status updates until a problem is fixed. Very few vendors anywhere in this index publish a route for a security researcher to reach them at all, and doing so is a genuine maturity signal even without an attestation behind it. Named infrastructure hosting on Amazon Web Services is also more than most disclose.

Ask whether a SOC 2 is planned or underway.

CC on FDA and Regulatory StatusNo device claim is made and the product is scoped accordingly. Most administrative and operational products sit here and are not penalised for it, because this axis grades the appropriateness of the positioning rather than possession of a clearance.
Vendor Published

No FDA clearance or device authorisation was located and none is expected, since the output informs a legal, claims or evaluation process rather than a diagnosis or treatment decision. The relevant exposure sits elsewhere: evidentiary and discovery rules where a chronology supports expert testimony, professional obligations governing an expert witness's reliance on assistive tools, and state workers compensation and independent evaluation regulation.

CC on AI Governance and Bias DisclosureResponsible artificial intelligence is committed to in policy language with no evaluation behind it. Most of the index sits here.
Vendor Published

The grade describes disclosure, and one item on this record is the strongest governance behaviour found anywhere in the medicolegal group. Quench publicly declines a capability that would sell: it states its AI does not cite cases or draw conclusions, and confines itself to organising, chronologising and locating information.

In a market where a direct competitor in this index markets inference as its central differentiator, describing its product as drawing conclusions about whether a condition progressed, that is a deliberate limitation on a revenue generating surface and it is the correct one for a use case where an inference error cannot be caught by checking a source. It also publishes a vulnerability disclosure process and names its clinical advisers rather than hiding behind anonymous endorsement.

Held at C because nothing is measured: no accuracy figure, no fairness, subgroup or demographic performance disclosure of any kind, and no published evaluation. Publishing any accuracy or subgroup data would move this to B immediately, and the company is closer to deserving it than most of this group.

DD on AI Liability and RecourseNothing published on what happens when the system is wrong.
Vendor Published

An unusual inversion of the normal gap sits on this record and it is worth naming as a category. Most vendors in this index say nothing about what they run on. This one says what it is not, with the founder stating that the product is not a consumer chat product and not just a wrapper, and describing sophisticated proprietary engineering, without saying what the stack actually is.

A negative claim is not a disclosure: it forecloses one reading while establishing nothing, it cannot be checked, and it invites a buyer to supply a flattering inference about what sits behind it. It also tends to appear precisely where the positive statement would be easy to make, which is what makes it worth flagging rather than ignoring. Beyond it there is nothing.

No model or model family is named, no accuracy figure exists for extraction, chronology construction or the question answering interface, no evaluation methodology was located, and no warranty, indemnity or remediation commitment attaches. The chronology is the component to press, because building a timeline from a disordered file is where a document review product creates its own version of events, and an omitted or misdated entry changes the narrative a decision rests on.

The interface is described as returning documented answers, which suggests citation to source, and the granularity is unspecified. Ask what the stack is, for accuracy on chronology construction, and the citation granularity.

Integration and Deployment
CC on EHR and Interoperability DepthIntegration is claimed through standards or a middleware layer with no system named and nothing to verify.
Vendor Published

Graded against what this product is rather than penalised for a mismatch. There is no EHR integration and none should be expected, since the users are expert witnesses, evaluators, law firms and insurers who do not operate one. Ingestion is document upload, handling large disorganised PDF sets, and review happens inside the platform with what the company describes as Adobe like precision, which keeps the reviewer in one tool rather than switching between a viewer and a summary. No API, case management integration or standards based exchange was located, so the product sits as an island in the reviewer's workflow.

CC on Deployment Model and Data ResidencyA single hosted option with location implied rather than committed.
Vendor Published

Hosted software running on Amazon Web Services, which is named explicitly and is more than most vendors in this category disclose, with the company citing AWS data centre physical access controls as part of its security posture. No region, residency commitment, customer hosted option or data location choice was located. Graded C because the hosting arrangement is clear and the residency picture is absent.

Commercial
CC on Commercial TransparencyNo price is published and the posture is discoverable: a buyer can establish how the product is sold and what drives the cost before contacting the vendor. Most of the index sits here.
Vendor Published

No price, tier or pricing mechanism was located.

The company does offer a self service free trial with an open sign up, which is a lower friction commercial route than the demo request that gates most of this category and lets a reviewer test the product on their own records before any conversation. That is credited, but it is access rather than price. Publishing the tiers behind that trial would be straightforward for a product sold to individual practitioners and small firms, and would move this record up.

BB on Setting and Specialty CoverageCoverage is named with validation behind part of it.
Vendor Published

Broad across matter types and reviewer roles rather than clinical specialties, which is the right measure for a medicolegal product. Named coverage spans workers compensation claims, standard of care evaluation, injury from defective products, litigation, claims disputes and underwriting, and the user set includes physicians and nurses acting as expert witnesses, independent medical examiners, qualified medical evaluators, law firms and insurance companies.

The occupational health emphasis is genuine rather than incidental, reflected in both named clinical advisers and in the workers compensation and independent evaluation focus. Graded B rather than A because depth within any single matter type is asserted rather than demonstrated.

Comparisons

Compared With

Each comparison carries a written verdict, the buyer conditions that favor each vendor, and a graded side by side. Pairs that cross a category boundary are grouped separately, and their verdicts state where the boundary sits rather than manufacturing a head to head.

Commercial

Pricing

Vendor-published figures are labeled as such. Figures labeled “Estimated” are derived from third-party sources and have not been confirmed by the vendor.

Entry Price Pricing Basis BAA Tier Implementation Source
Not published. A self service free trial is offered.
Undisclosed. Sold to expert witnesses, independent and qualified medical evaluators, law firms and insurance companies. Not published. Establish first whether HIPAA governs your matters at all, since medicolegal records typically arrive under authorisation, subpoena or discovery. None described. The product is document upload into a hosted platform with no integration work stated. Vendor Published

No price, tier or pricing mechanism was located, so commercial transparency is Not Rated per the house convention rather than graded down. The company does offer a self service free trial with open sign up, which is a materially lower friction route than the demo request gating most of this category and lets a reviewer test the product on their own case file before any sales conversation. Use it, and measure on a matter you already know the answer to.

Four things to establish. The pricing unit, since per case, per page, per seat and subscription models behave very differently for an independent medical examiner working a handful of large files versus a firm running volume. Whether uploaded records are used to train or improve models, since the company publishes no commitment either way and the records belong to examinees who are frequently the opposing party. What happens to a case file after a matter closes, given no retention period is published and a closed medicolegal file has no ongoing purpose. And whether a SOC 2 or equivalent attestation exists or is underway, since none was located and an insurer or law firm procurement will ask.

One thing worth valuing rather than negotiating: the company publicly limits its AI to organising, chronologising and locating information, and states it does not draw conclusions. If that matters to your risk posture, get it written into the agreement rather than relying on a webpage.